Revitalist Lifestyle and Wellness Ltd. Stock Canadian Securities Exchange

Stocks

CALM

CA76151T1030

Healthcare Facilities & Services

OTC Markets Traded
Market Closed - 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Revitalist Lifestyle and Wellness Ltd. -.--% -

Valuation : Revitalist Lifestyle and Wellness Ltd.

Market Cap 2.97M 2.56M 2.4M 2.19M 4.12M 284M 4.14M 28.45M 11.1M 143M 11.14M 10.9M 475M P/E 2021
-0.83x
P/E 2022 -0.12x
Enterprise Value 12.77M 11.01M 10.32M 9.42M 17.75M 1.22B 17.8M 122M 47.77M 616M 47.95M 46.91M 2.04B EV / Sales 2021
6,424,266x
EV / Sales 2022 369,034x
Free-Float
98.18%
Yield 2021 *
-
Yield 2022 -
5 years 0
Extreme 0
0.88
10 years 0
Extreme 0
0.88
Manager TitleAgeSince
Chief Operating Officer - 30/03/2023
Sales & Marketing - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 137
+0.15%+0.04%+29.00%+38.40% 119B
-0.36%-2.65%+2.59%+50.54% 90.46B
-0.75%-1.60%-1.09%+55.28% 29.97B
-0.76%-0.67%+35.47%+83.30% 26.79B
+0.42%+1.35%0.00%-3.29% 22.47B
-0.35%-4.98%+44.58%+249.26% 21.48B
+0.37%+3.47%-9.22%+21.62% 14.84B
-0.52%-0.55%-7.38%-10.15% 12.28B
+1.01%+3.95%+32.82%+79.69% 11.52B
Average -0.08%-0.05%+14.09%+62.74% 38.76B
Weighted average by Cap. -0.13%-0.72%+16.37%+55.69%

Financials

2021 2022
Net sales 2.07 1.78 1.67 1.52 2.87 197.6 2.88 19.82 7.73 99.74 7.76 7.59 330.74 4.57 3.93 3.69 3.37 6.34 436.3 6.36 43.76 17.07 220.24 17.14 16.77 730.29
Net income -12.61M -10.87M -10.19M -9.3M -17.52M -1.21B -17.57M -121M -47.16M -608M -47.34M -46.31M -2.02B -13.63M -11.74M -11.01M -10.05M -18.94M -1.3B -19M -131M -50.97M -658M -51.17M -50.06M -2.18B
Net Debt 1.6 1.38 1.29 1.18 2.22 152.78 2.23 15.32 5.98 77.12 6 5.87 255.73 9.8 8.45 7.92 7.23 13.62 937.04 13.67 93.98 36.67 473.01 36.81 36.01 1.57K
Logo Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. is a mental health and wellness company focused on comprehensive care in the ketamine wellness space. The Company, through its Tennessee subsidiary, Revitalist LLC, operates physical locations in three states, virtual offices across six states and medical and behavioral services in two countries. The Company’s segments include Clinical Operations and Research. The Clinical Operations segment encompasses the Company’s ketamine assisted psychotherapy clinics across the United States. The Research segment consists of the development of virtual clinics in the metaverse and research focused expenses. The Company offers various therapies, such as Ketamine Therapy, Home Ketamine Therapy, Ketamine Assisted Psychotherapy, Spravato, Vitamin Therapy, Neuropeptide Therapy and Supplements. It offers treatment for various conditions, including Anxiety, Depression, PTSD, OCD, Bipolar Disorder, Pain, Suicidal Ideation and Substance Abuse.
Employees
-